nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—ABCB1—Mitomycin—urinary bladder cancer	0.113	0.506	CbGbCtD
Lamotrigine—ABCB1—Gemcitabine—urinary bladder cancer	0.0326	0.146	CbGbCtD
Lamotrigine—ABCB1—Cisplatin—urinary bladder cancer	0.0237	0.106	CbGbCtD
Lamotrigine—ABCB1—Etoposide—urinary bladder cancer	0.0233	0.104	CbGbCtD
Lamotrigine—ABCB1—Doxorubicin—urinary bladder cancer	0.0159	0.0709	CbGbCtD
Lamotrigine—ABCB1—Methotrexate—urinary bladder cancer	0.0154	0.0686	CbGbCtD
Lamotrigine—SCN9A—prostate gland—urinary bladder cancer	0.00239	0.127	CbGeAlD
Lamotrigine—UGT1A4—renal system—urinary bladder cancer	0.00234	0.124	CbGeAlD
Lamotrigine—SCN4A—prostate gland—urinary bladder cancer	0.00213	0.113	CbGeAlD
Lamotrigine—SCN3A—prostate gland—urinary bladder cancer	0.00166	0.0882	CbGeAlD
Lamotrigine—SCN4A—renal system—urinary bladder cancer	0.00146	0.0773	CbGeAlD
Lamotrigine—SCN3A—renal system—urinary bladder cancer	0.00113	0.0601	CbGeAlD
Lamotrigine—SCN2A—vagina—urinary bladder cancer	0.000933	0.0496	CbGeAlD
Lamotrigine—SCN3A—female reproductive system—urinary bladder cancer	0.000906	0.0482	CbGeAlD
Lamotrigine—SCN3A—vagina—urinary bladder cancer	0.00082	0.0436	CbGeAlD
Lamotrigine—SCN5A—vagina—urinary bladder cancer	0.000817	0.0434	CbGeAlD
Lamotrigine—SCN9A—lymph node—urinary bladder cancer	0.000764	0.0406	CbGeAlD
Lamotrigine—SCN10A—lymph node—urinary bladder cancer	0.000582	0.0309	CbGeAlD
Lamotrigine—SCN3A—lymph node—urinary bladder cancer	0.00053	0.0282	CbGeAlD
Lamotrigine—ABCB1—prostate gland—urinary bladder cancer	0.000447	0.0237	CbGeAlD
Lamotrigine—ABCB1—seminal vesicle—urinary bladder cancer	0.000378	0.0201	CbGeAlD
Lamotrigine—ABCB1—epithelium—urinary bladder cancer	0.000328	0.0174	CbGeAlD
Lamotrigine—ABCB1—renal system—urinary bladder cancer	0.000304	0.0162	CbGeAlD
Lamotrigine—ABCB1—urethra—urinary bladder cancer	0.000299	0.0159	CbGeAlD
Lamotrigine—ABCB1—female reproductive system—urinary bladder cancer	0.000244	0.013	CbGeAlD
Lamotrigine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000225	0.000436	CcSEcCtD
Lamotrigine—Stomatitis—Doxorubicin—urinary bladder cancer	0.000225	0.000436	CcSEcCtD
Lamotrigine—Rhinitis—Epirubicin—urinary bladder cancer	0.000224	0.000435	CcSEcCtD
Lamotrigine—Abdominal pain—Etoposide—urinary bladder cancer	0.000224	0.000434	CcSEcCtD
Lamotrigine—Body temperature increased—Etoposide—urinary bladder cancer	0.000224	0.000434	CcSEcCtD
Lamotrigine—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000224	0.000434	CcSEcCtD
Lamotrigine—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000224	0.000434	CcSEcCtD
Lamotrigine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000223	0.000434	CcSEcCtD
Lamotrigine—Hepatitis—Epirubicin—urinary bladder cancer	0.000223	0.000434	CcSEcCtD
Lamotrigine—Eye disorder—Methotrexate—urinary bladder cancer	0.000223	0.000433	CcSEcCtD
Lamotrigine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000223	0.000433	CcSEcCtD
Lamotrigine—Tinnitus—Methotrexate—urinary bladder cancer	0.000223	0.000432	CcSEcCtD
Lamotrigine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000222	0.000431	CcSEcCtD
Lamotrigine—Asthenia—Cisplatin—urinary bladder cancer	0.000222	0.00043	CcSEcCtD
Lamotrigine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000222	0.00043	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—RHOA—urinary bladder cancer	0.000221	0.000914	CbGpPWpGaD
Lamotrigine—Sweating—Doxorubicin—urinary bladder cancer	0.000221	0.000428	CcSEcCtD
Lamotrigine—ABCB1—vagina—urinary bladder cancer	0.00022	0.0117	CbGeAlD
Lamotrigine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00022	0.000427	CcSEcCtD
Lamotrigine—Haematuria—Doxorubicin—urinary bladder cancer	0.00022	0.000426	CcSEcCtD
Lamotrigine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00022	0.000426	CcSEcCtD
Lamotrigine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000217	0.000422	CcSEcCtD
Lamotrigine—Angiopathy—Methotrexate—urinary bladder cancer	0.000217	0.00042	CcSEcCtD
Lamotrigine—Sinusitis—Doxorubicin—urinary bladder cancer	0.000216	0.000419	CcSEcCtD
Lamotrigine—Dizziness—Fluorouracil—urinary bladder cancer	0.000216	0.000418	CcSEcCtD
Lamotrigine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000215	0.000418	CcSEcCtD
Lamotrigine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000215	0.000417	CcSEcCtD
Lamotrigine—Chills—Methotrexate—urinary bladder cancer	0.000214	0.000416	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—ERBB2—urinary bladder cancer	0.000214	0.000884	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—RHOA—urinary bladder cancer	0.000212	0.000878	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—RHOA—urinary bladder cancer	0.000212	0.000878	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000212	0.000875	CbGpPWpGaD
Lamotrigine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000212	0.00041	CcSEcCtD
Lamotrigine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000211	0.00041	CcSEcCtD
Lamotrigine—Alopecia—Methotrexate—urinary bladder cancer	0.000211	0.000409	CcSEcCtD
Lamotrigine—Vomiting—Gemcitabine—urinary bladder cancer	0.000211	0.000409	CcSEcCtD
Lamotrigine—Mental disorder—Methotrexate—urinary bladder cancer	0.000209	0.000406	CcSEcCtD
Lamotrigine—Rash—Gemcitabine—urinary bladder cancer	0.000209	0.000406	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—SRC—urinary bladder cancer	0.000209	0.000865	CbGpPWpGaD
Lamotrigine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000209	0.000405	CcSEcCtD
Lamotrigine—Eye disorder—Epirubicin—urinary bladder cancer	0.000209	0.000405	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—CDK4—urinary bladder cancer	0.000209	0.000863	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000209	0.000405	CcSEcCtD
Lamotrigine—Tinnitus—Epirubicin—urinary bladder cancer	0.000208	0.000404	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—CYP4B1—urinary bladder cancer	0.000208	0.00086	CbGpPWpGaD
Lamotrigine—Erythema—Methotrexate—urinary bladder cancer	0.000208	0.000403	CcSEcCtD
Lamotrigine—Malnutrition—Methotrexate—urinary bladder cancer	0.000208	0.000403	CcSEcCtD
Lamotrigine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000208	0.000403	CcSEcCtD
Lamotrigine—Headache—Gemcitabine—urinary bladder cancer	0.000208	0.000403	CcSEcCtD
Lamotrigine—Flushing—Epirubicin—urinary bladder cancer	0.000207	0.000402	CcSEcCtD
Lamotrigine—Vomiting—Fluorouracil—urinary bladder cancer	0.000207	0.000402	CcSEcCtD
Lamotrigine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000207	0.000402	CcSEcCtD
Lamotrigine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000207	0.000401	CcSEcCtD
Lamotrigine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000207	0.000401	CcSEcCtD
Lamotrigine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000206	0.000399	CcSEcCtD
Lamotrigine—Rash—Fluorouracil—urinary bladder cancer	0.000206	0.000399	CcSEcCtD
Lamotrigine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000205	0.000399	CcSEcCtD
Lamotrigine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000205	0.000398	CcSEcCtD
Lamotrigine—SCN10A—Axon guidance—RHOA—urinary bladder cancer	0.000205	0.000846	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—RHOA—urinary bladder cancer	0.000205	0.000846	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—ERBB2—urinary bladder cancer	0.000204	0.000846	CbGpPWpGaD
Lamotrigine—Headache—Fluorouracil—urinary bladder cancer	0.000204	0.000396	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—RHOA—urinary bladder cancer	0.000204	0.000843	CbGpPWpGaD
Lamotrigine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000204	0.000395	CcSEcCtD
Lamotrigine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000204	0.000395	CcSEcCtD
Lamotrigine—Asthenia—Etoposide—urinary bladder cancer	0.000203	0.000394	CcSEcCtD
Lamotrigine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000203	0.000394	CcSEcCtD
Lamotrigine—Angiopathy—Epirubicin—urinary bladder cancer	0.000203	0.000393	CcSEcCtD
Lamotrigine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000201	0.000391	CcSEcCtD
Lamotrigine—Back pain—Methotrexate—urinary bladder cancer	0.000201	0.00039	CcSEcCtD
Lamotrigine—Chills—Epirubicin—urinary bladder cancer	0.000201	0.000389	CcSEcCtD
Lamotrigine—Pruritus—Etoposide—urinary bladder cancer	0.0002	0.000389	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—CDK4—urinary bladder cancer	0.0002	0.000826	CbGpPWpGaD
Lamotrigine—Alopecia—Epirubicin—urinary bladder cancer	0.000197	0.000383	CcSEcCtD
Lamotrigine—Nausea—Gemcitabine—urinary bladder cancer	0.000197	0.000382	CcSEcCtD
Lamotrigine—Vomiting—Cisplatin—urinary bladder cancer	0.000197	0.000381	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—ERBB2—urinary bladder cancer	0.000196	0.000812	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—ERBB2—urinary bladder cancer	0.000196	0.000812	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—SLC19A1—urinary bladder cancer	0.000196	0.000812	CbGpPWpGaD
Lamotrigine—Vision blurred—Methotrexate—urinary bladder cancer	0.000196	0.00038	CcSEcCtD
Lamotrigine—Mental disorder—Epirubicin—urinary bladder cancer	0.000196	0.00038	CcSEcCtD
Lamotrigine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000195	0.000379	CcSEcCtD
Lamotrigine—Rash—Cisplatin—urinary bladder cancer	0.000195	0.000378	CcSEcCtD
Lamotrigine—Dermatitis—Cisplatin—urinary bladder cancer	0.000195	0.000378	CcSEcCtD
Lamotrigine—Erythema—Epirubicin—urinary bladder cancer	0.000195	0.000377	CcSEcCtD
Lamotrigine—Malnutrition—Epirubicin—urinary bladder cancer	0.000195	0.000377	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000194	0.000804	CbGpPWpGaD
Lamotrigine—Diarrhoea—Etoposide—urinary bladder cancer	0.000194	0.000376	CcSEcCtD
Lamotrigine—Nausea—Fluorouracil—urinary bladder cancer	0.000194	0.000376	CcSEcCtD
Lamotrigine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000193	0.000375	CcSEcCtD
Lamotrigine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000193	0.000374	CcSEcCtD
Lamotrigine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000193	0.000374	CcSEcCtD
Lamotrigine—Anaemia—Methotrexate—urinary bladder cancer	0.000192	0.000373	CcSEcCtD
Lamotrigine—Flushing—Doxorubicin—urinary bladder cancer	0.000192	0.000372	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—CDK4—urinary bladder cancer	0.000192	0.000793	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CDK4—urinary bladder cancer	0.000192	0.000793	CbGpPWpGaD
Lamotrigine—Flatulence—Epirubicin—urinary bladder cancer	0.000192	0.000372	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—PRSS3—urinary bladder cancer	0.000191	0.000792	CbGpPWpGaD
Lamotrigine—Tension—Epirubicin—urinary bladder cancer	0.000191	0.00037	CcSEcCtD
Lamotrigine—Dysgeusia—Epirubicin—urinary bladder cancer	0.00019	0.00037	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—PPARG—urinary bladder cancer	0.00019	0.000784	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—ERBB2—urinary bladder cancer	0.000189	0.000783	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—ERBB2—urinary bladder cancer	0.000189	0.000783	CbGpPWpGaD
Lamotrigine—Nervousness—Epirubicin—urinary bladder cancer	0.000189	0.000367	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—ERBB2—urinary bladder cancer	0.000189	0.00078	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000189	0.00078	CbGpPWpGaD
Lamotrigine—Back pain—Epirubicin—urinary bladder cancer	0.000188	0.000365	CcSEcCtD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000188	0.000776	CbGpPWpGaD
Lamotrigine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000188	0.000364	CcSEcCtD
Lamotrigine—Malaise—Methotrexate—urinary bladder cancer	0.000187	0.000364	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000187	0.000775	CbGpPWpGaD
Lamotrigine—Dizziness—Etoposide—urinary bladder cancer	0.000187	0.000363	CcSEcCtD
Lamotrigine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000187	0.000363	CcSEcCtD
Lamotrigine—Vertigo—Methotrexate—urinary bladder cancer	0.000187	0.000362	CcSEcCtD
Lamotrigine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000186	0.000362	CcSEcCtD
Lamotrigine—Leukopenia—Methotrexate—urinary bladder cancer	0.000186	0.000361	CcSEcCtD
Lamotrigine—Chills—Doxorubicin—urinary bladder cancer	0.000186	0.00036	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—CDK4—urinary bladder cancer	0.000185	0.000765	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CDK4—urinary bladder cancer	0.000185	0.000765	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—TYMP—urinary bladder cancer	0.000184	0.000761	CbGpPWpGaD
Lamotrigine—Nausea—Cisplatin—urinary bladder cancer	0.000184	0.000356	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—MMP9—urinary bladder cancer	0.000183	0.000758	CbGpPWpGaD
Lamotrigine—Vision blurred—Epirubicin—urinary bladder cancer	0.000183	0.000356	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—EGFR—urinary bladder cancer	0.000183	0.000758	CbGpPWpGaD
Lamotrigine—Alopecia—Doxorubicin—urinary bladder cancer	0.000183	0.000354	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—CREBBP—urinary bladder cancer	0.000182	0.000753	CbGpPWpGaD
Lamotrigine—Cough—Methotrexate—urinary bladder cancer	0.000181	0.000352	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—PPARG—urinary bladder cancer	0.000181	0.00075	CbGpPWpGaD
Lamotrigine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000181	0.000351	CcSEcCtD
Lamotrigine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00018	0.00035	CcSEcCtD
Lamotrigine—Convulsion—Methotrexate—urinary bladder cancer	0.00018	0.000349	CcSEcCtD
Lamotrigine—Vomiting—Etoposide—urinary bladder cancer	0.00018	0.000349	CcSEcCtD
Lamotrigine—Erythema—Doxorubicin—urinary bladder cancer	0.00018	0.000349	CcSEcCtD
Lamotrigine—Malnutrition—Doxorubicin—urinary bladder cancer	0.00018	0.000349	CcSEcCtD
Lamotrigine—Anaemia—Epirubicin—urinary bladder cancer	0.00018	0.000349	CcSEcCtD
Lamotrigine—Agitation—Epirubicin—urinary bladder cancer	0.000179	0.000347	CcSEcCtD
Lamotrigine—Rash—Etoposide—urinary bladder cancer	0.000179	0.000346	CcSEcCtD
Lamotrigine—Dermatitis—Etoposide—urinary bladder cancer	0.000178	0.000346	CcSEcCtD
Lamotrigine—Headache—Etoposide—urinary bladder cancer	0.000177	0.000344	CcSEcCtD
Lamotrigine—Flatulence—Doxorubicin—urinary bladder cancer	0.000177	0.000344	CcSEcCtD
Lamotrigine—Chest pain—Methotrexate—urinary bladder cancer	0.000177	0.000343	CcSEcCtD
Lamotrigine—Arthralgia—Methotrexate—urinary bladder cancer	0.000177	0.000343	CcSEcCtD
Lamotrigine—Myalgia—Methotrexate—urinary bladder cancer	0.000177	0.000343	CcSEcCtD
Lamotrigine—Tension—Doxorubicin—urinary bladder cancer	0.000177	0.000343	CcSEcCtD
Lamotrigine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000176	0.000342	CcSEcCtD
Lamotrigine—Malaise—Epirubicin—urinary bladder cancer	0.000175	0.00034	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—MMP9—urinary bladder cancer	0.000175	0.000725	CbGpPWpGaD
Lamotrigine—Discomfort—Methotrexate—urinary bladder cancer	0.000175	0.000339	CcSEcCtD
Lamotrigine—Nervousness—Doxorubicin—urinary bladder cancer	0.000175	0.000339	CcSEcCtD
Lamotrigine—Vertigo—Epirubicin—urinary bladder cancer	0.000175	0.000339	CcSEcCtD
Lamotrigine—Syncope—Epirubicin—urinary bladder cancer	0.000174	0.000338	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—PPARG—urinary bladder cancer	0.000174	0.000721	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—PPARG—urinary bladder cancer	0.000174	0.000721	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—CREBBP—urinary bladder cancer	0.000174	0.000721	CbGpPWpGaD
Lamotrigine—Leukopenia—Epirubicin—urinary bladder cancer	0.000174	0.000338	CcSEcCtD
Lamotrigine—Back pain—Doxorubicin—urinary bladder cancer	0.000174	0.000338	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—KRAS—urinary bladder cancer	0.000173	0.000716	CbGpPWpGaD
Lamotrigine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000173	0.000336	CcSEcCtD
Lamotrigine—Palpitations—Epirubicin—urinary bladder cancer	0.000172	0.000334	CcSEcCtD
Lamotrigine—Confusional state—Methotrexate—urinary bladder cancer	0.000171	0.000332	CcSEcCtD
Lamotrigine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000171	0.000332	CcSEcCtD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000171	0.000707	CbGpPWpGaD
Lamotrigine—Cough—Epirubicin—urinary bladder cancer	0.00017	0.000329	CcSEcCtD
Lamotrigine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00017	0.000329	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—SRC—urinary bladder cancer	0.000169	0.000699	CbGpPWpGaD
Lamotrigine—Convulsion—Epirubicin—urinary bladder cancer	0.000169	0.000327	CcSEcCtD
Lamotrigine—Infection—Methotrexate—urinary bladder cancer	0.000169	0.000327	CcSEcCtD
Lamotrigine—SCN2A—Axon guidance—MMP9—urinary bladder cancer	0.000169	0.000697	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MMP9—urinary bladder cancer	0.000169	0.000697	CbGpPWpGaD
Lamotrigine—Nausea—Etoposide—urinary bladder cancer	0.000168	0.000326	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—PPARG—urinary bladder cancer	0.000168	0.000695	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—PPARG—urinary bladder cancer	0.000168	0.000695	CbGpPWpGaD
Lamotrigine—Hypertension—Epirubicin—urinary bladder cancer	0.000168	0.000326	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—CREBBP—urinary bladder cancer	0.000167	0.000692	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—CREBBP—urinary bladder cancer	0.000167	0.000692	CbGpPWpGaD
Lamotrigine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000167	0.000324	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—NAT2—urinary bladder cancer	0.000166	0.000689	CbGpPWpGaD
Lamotrigine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000166	0.000323	CcSEcCtD
Lamotrigine—Anaemia—Doxorubicin—urinary bladder cancer	0.000166	0.000323	CcSEcCtD
Lamotrigine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000166	0.000322	CcSEcCtD
Lamotrigine—Arthralgia—Epirubicin—urinary bladder cancer	0.000166	0.000321	CcSEcCtD
Lamotrigine—Myalgia—Epirubicin—urinary bladder cancer	0.000166	0.000321	CcSEcCtD
Lamotrigine—Chest pain—Epirubicin—urinary bladder cancer	0.000166	0.000321	CcSEcCtD
Lamotrigine—Agitation—Doxorubicin—urinary bladder cancer	0.000165	0.000321	CcSEcCtD
Lamotrigine—Anxiety—Epirubicin—urinary bladder cancer	0.000165	0.00032	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—NCOR1—urinary bladder cancer	0.000165	0.000682	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—RHOA—urinary bladder cancer	0.000165	0.000682	CbGpPWpGaD
Lamotrigine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000164	0.000318	CcSEcCtD
Lamotrigine—Discomfort—Epirubicin—urinary bladder cancer	0.000164	0.000317	CcSEcCtD
Lamotrigine—SCN10A—Axon guidance—MMP9—urinary bladder cancer	0.000162	0.000672	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MMP9—urinary bladder cancer	0.000162	0.000672	CbGpPWpGaD
Lamotrigine—Malaise—Doxorubicin—urinary bladder cancer	0.000162	0.000315	CcSEcCtD
Lamotrigine—Dry mouth—Epirubicin—urinary bladder cancer	0.000162	0.000314	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—MMP9—urinary bladder cancer	0.000162	0.000669	CbGpPWpGaD
Lamotrigine—Vertigo—Doxorubicin—urinary bladder cancer	0.000162	0.000314	CcSEcCtD
Lamotrigine—Anorexia—Methotrexate—urinary bladder cancer	0.000162	0.000314	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—SRC—urinary bladder cancer	0.000162	0.000669	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CREBBP—urinary bladder cancer	0.000161	0.000668	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CREBBP—urinary bladder cancer	0.000161	0.000668	CbGpPWpGaD
Lamotrigine—Syncope—Doxorubicin—urinary bladder cancer	0.000161	0.000313	CcSEcCtD
Lamotrigine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000161	0.000313	CcSEcCtD
Lamotrigine—Confusional state—Epirubicin—urinary bladder cancer	0.00016	0.000311	CcSEcCtD
Lamotrigine—Palpitations—Doxorubicin—urinary bladder cancer	0.000159	0.000309	CcSEcCtD
Lamotrigine—Oedema—Epirubicin—urinary bladder cancer	0.000159	0.000308	CcSEcCtD
Lamotrigine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000158	0.000307	CcSEcCtD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000158	0.000652	CbGpPWpGaD
Lamotrigine—Infection—Epirubicin—urinary bladder cancer	0.000158	0.000306	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—RHOA—urinary bladder cancer	0.000158	0.000652	CbGpPWpGaD
Lamotrigine—Cough—Doxorubicin—urinary bladder cancer	0.000157	0.000305	CcSEcCtD
Lamotrigine—Shock—Epirubicin—urinary bladder cancer	0.000156	0.000303	CcSEcCtD
Lamotrigine—Convulsion—Doxorubicin—urinary bladder cancer	0.000156	0.000303	CcSEcCtD
Lamotrigine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000156	0.000302	CcSEcCtD
Lamotrigine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000155	0.000302	CcSEcCtD
Lamotrigine—Hypertension—Doxorubicin—urinary bladder cancer	0.000155	0.000302	CcSEcCtD
Lamotrigine—SCN4A—Axon guidance—SRC—urinary bladder cancer	0.000155	0.000643	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—SRC—urinary bladder cancer	0.000155	0.000643	CbGpPWpGaD
Lamotrigine—Tachycardia—Epirubicin—urinary bladder cancer	0.000155	0.000301	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000155	0.0003	CcSEcCtD
Lamotrigine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000153	0.000298	CcSEcCtD
Lamotrigine—Insomnia—Methotrexate—urinary bladder cancer	0.000153	0.000298	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—EP300—urinary bladder cancer	0.000153	0.000634	CbGpPWpGaD
Lamotrigine—Chest pain—Doxorubicin—urinary bladder cancer	0.000153	0.000297	CcSEcCtD
Lamotrigine—Myalgia—Doxorubicin—urinary bladder cancer	0.000153	0.000297	CcSEcCtD
Lamotrigine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000153	0.000297	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—TYMP—urinary bladder cancer	0.000153	0.000633	CbGpPWpGaD
Lamotrigine—Anxiety—Doxorubicin—urinary bladder cancer	0.000153	0.000296	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—ERBB2—urinary bladder cancer	0.000153	0.000631	CbGpPWpGaD
Lamotrigine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000152	0.000296	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—RHOA—urinary bladder cancer	0.000151	0.000626	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—RHOA—urinary bladder cancer	0.000151	0.000626	CbGpPWpGaD
Lamotrigine—Discomfort—Doxorubicin—urinary bladder cancer	0.000151	0.000294	CcSEcCtD
Lamotrigine—Anorexia—Epirubicin—urinary bladder cancer	0.000151	0.000294	CcSEcCtD
Lamotrigine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000151	0.000293	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000151	0.000624	CbGpPWpGaD
Lamotrigine—Somnolence—Methotrexate—urinary bladder cancer	0.000151	0.000293	CcSEcCtD
Lamotrigine—Dry mouth—Doxorubicin—urinary bladder cancer	0.00015	0.000291	CcSEcCtD
Lamotrigine—SCN1A—Axon guidance—SRC—urinary bladder cancer	0.00015	0.00062	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—SRC—urinary bladder cancer	0.00015	0.00062	CbGpPWpGaD
Lamotrigine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000149	0.00029	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—SRC—urinary bladder cancer	0.000149	0.000617	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—EGFR—urinary bladder cancer	0.000148	0.000613	CbGpPWpGaD
Lamotrigine—Confusional state—Doxorubicin—urinary bladder cancer	0.000148	0.000287	CcSEcCtD
Lamotrigine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000147	0.000286	CcSEcCtD
Lamotrigine—SCN8A—Axon guidance—HRAS—urinary bladder cancer	0.000147	0.000608	CbGpPWpGaD
Lamotrigine—Oedema—Doxorubicin—urinary bladder cancer	0.000147	0.000285	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000146	0.000284	CcSEcCtD
Lamotrigine—Fatigue—Methotrexate—urinary bladder cancer	0.000146	0.000284	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—RHOA—urinary bladder cancer	0.000146	0.000604	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—RHOA—urinary bladder cancer	0.000146	0.000604	CbGpPWpGaD
Lamotrigine—Infection—Doxorubicin—urinary bladder cancer	0.000146	0.000283	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—ERBB2—urinary bladder cancer	0.000146	0.000603	CbGpPWpGaD
Lamotrigine—Pain—Methotrexate—urinary bladder cancer	0.000145	0.000281	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000145	0.000281	CcSEcCtD
Lamotrigine—Shock—Doxorubicin—urinary bladder cancer	0.000145	0.00028	CcSEcCtD
Lamotrigine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000144	0.00028	CcSEcCtD
Lamotrigine—SCN5A—Axon guidance—RHOA—urinary bladder cancer	0.000144	0.000595	CbGpPWpGaD
Lamotrigine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000144	0.000279	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—RRM2—urinary bladder cancer	0.000144	0.000594	CbGpPWpGaD
Lamotrigine—Insomnia—Epirubicin—urinary bladder cancer	0.000144	0.000279	CcSEcCtD
Lamotrigine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000143	0.000278	CcSEcCtD
Lamotrigine—ABCB1—lymph node—urinary bladder cancer	0.000143	0.00758	CbGeAlD
Lamotrigine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000143	0.000277	CcSEcCtD
Lamotrigine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000142	0.000276	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—EGFR—urinary bladder cancer	0.000142	0.000586	CbGpPWpGaD
Lamotrigine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000142	0.000275	CcSEcCtD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000141	0.000585	CbGpPWpGaD
Lamotrigine—Somnolence—Epirubicin—urinary bladder cancer	0.000141	0.000274	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—ERBB2—urinary bladder cancer	0.00014	0.00058	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—ERBB2—urinary bladder cancer	0.00014	0.00058	CbGpPWpGaD
Lamotrigine—Anorexia—Doxorubicin—urinary bladder cancer	0.00014	0.000272	CcSEcCtD
Lamotrigine—SCN9A—Axon guidance—KRAS—urinary bladder cancer	0.00014	0.000579	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00014	0.000271	CcSEcCtD
Lamotrigine—Dyspepsia—Epirubicin—urinary bladder cancer	0.00014	0.000271	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000139	0.000269	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—NAT2—urinary bladder cancer	0.000138	0.000572	CbGpPWpGaD
Lamotrigine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000138	0.000268	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000137	0.000266	CcSEcCtD
Lamotrigine—Fatigue—Epirubicin—urinary bladder cancer	0.000137	0.000266	CcSEcCtD
Lamotrigine—SCN2A—Axon guidance—EGFR—urinary bladder cancer	0.000136	0.000563	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—EGFR—urinary bladder cancer	0.000136	0.000563	CbGpPWpGaD
Lamotrigine—Pain—Epirubicin—urinary bladder cancer	0.000136	0.000263	CcSEcCtD
Lamotrigine—Constipation—Epirubicin—urinary bladder cancer	0.000136	0.000263	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—ERBB2—urinary bladder cancer	0.000135	0.000559	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	0.000135	0.000559	CbGpPWpGaD
Lamotrigine—Urticaria—Methotrexate—urinary bladder cancer	0.000135	0.000261	CcSEcCtD
Lamotrigine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000134	0.00026	CcSEcCtD
Lamotrigine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000134	0.00026	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—KRAS—urinary bladder cancer	0.000134	0.000554	CbGpPWpGaD
Lamotrigine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000134	0.00026	CcSEcCtD
Lamotrigine—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	0.000133	0.000551	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—HPGDS—urinary bladder cancer	0.000133	0.00055	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ENO2—urinary bladder cancer	0.000133	0.00055	CbGpPWpGaD
Lamotrigine—Insomnia—Doxorubicin—urinary bladder cancer	0.000133	0.000258	CcSEcCtD
Lamotrigine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000132	0.000256	CcSEcCtD
Lamotrigine—SCN10A—Axon guidance—EGFR—urinary bladder cancer	0.000131	0.000543	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—EGFR—urinary bladder cancer	0.000131	0.000543	CbGpPWpGaD
Lamotrigine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000131	0.000254	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—MMP9—urinary bladder cancer	0.000131	0.000541	CbGpPWpGaD
Lamotrigine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000131	0.000254	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—EGFR—urinary bladder cancer	0.000131	0.000541	CbGpPWpGaD
Lamotrigine—Somnolence—Doxorubicin—urinary bladder cancer	0.000131	0.000253	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	0.00013	0.000538	CbGpPWpGaD
Lamotrigine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00013	0.000252	CcSEcCtD
Lamotrigine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000129	0.000251	CcSEcCtD
Lamotrigine—UGT1A4—Metabolism—GSTT1—urinary bladder cancer	0.000129	0.000534	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000129	0.000534	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—KRAS—urinary bladder cancer	0.000129	0.000532	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—KRAS—urinary bladder cancer	0.000129	0.000532	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000128	0.000529	CbGpPWpGaD
Lamotrigine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000128	0.000248	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000246	CcSEcCtD
Lamotrigine—Fatigue—Doxorubicin—urinary bladder cancer	0.000127	0.000246	CcSEcCtD
Lamotrigine—Urticaria—Epirubicin—urinary bladder cancer	0.000126	0.000245	CcSEcCtD
Lamotrigine—Pain—Doxorubicin—urinary bladder cancer	0.000126	0.000244	CcSEcCtD
Lamotrigine—Constipation—Doxorubicin—urinary bladder cancer	0.000126	0.000244	CcSEcCtD
Lamotrigine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000126	0.000244	CcSEcCtD
Lamotrigine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000126	0.000244	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—MMP9—urinary bladder cancer	0.000125	0.000518	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000125	0.000243	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—TNF—urinary bladder cancer	0.000125	0.000515	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—EP300—urinary bladder cancer	0.000124	0.000513	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—KRAS—urinary bladder cancer	0.000124	0.000513	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—KRAS—urinary bladder cancer	0.000124	0.000513	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000124	0.000511	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—KRAS—urinary bladder cancer	0.000124	0.000511	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.000123	0.00051	CbGpPWpGaD
Lamotrigine—Asthenia—Methotrexate—urinary bladder cancer	0.000122	0.000236	CcSEcCtD
Lamotrigine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000121	0.000235	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—SRC—urinary bladder cancer	0.000121	0.000499	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MMP9—urinary bladder cancer	0.00012	0.000497	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MMP9—urinary bladder cancer	0.00012	0.000497	CbGpPWpGaD
Lamotrigine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00012	0.000233	CcSEcCtD
Lamotrigine—Pruritus—Methotrexate—urinary bladder cancer	0.00012	0.000233	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00012	0.000496	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—RRM2—urinary bladder cancer	0.000119	0.000494	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—HRAS—urinary bladder cancer	0.000119	0.000492	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EP300—urinary bladder cancer	0.000119	0.000491	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	0.000118	0.000489	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000118	0.000487	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000117	0.000227	CcSEcCtD
Lamotrigine—Urticaria—Doxorubicin—urinary bladder cancer	0.000117	0.000226	CcSEcCtD
Lamotrigine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000116	0.000225	CcSEcCtD
Lamotrigine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000116	0.000225	CcSEcCtD
Lamotrigine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000116	0.000225	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	0.000116	0.00048	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MMP9—urinary bladder cancer	0.000116	0.00048	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—SRC—urinary bladder cancer	0.000115	0.000477	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MMP9—urinary bladder cancer	0.000114	0.000472	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EP300—urinary bladder cancer	0.000114	0.000472	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—EP300—urinary bladder cancer	0.000114	0.000472	CbGpPWpGaD
Lamotrigine—Asthenia—Epirubicin—urinary bladder cancer	0.000114	0.000221	CcSEcCtD
Lamotrigine—SCN3A—Axon guidance—HRAS—urinary bladder cancer	0.000114	0.000471	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	0.000113	0.000469	CbGpPWpGaD
Lamotrigine—Pruritus—Epirubicin—urinary bladder cancer	0.000112	0.000218	CcSEcCtD
Lamotrigine—Dizziness—Methotrexate—urinary bladder cancer	0.000112	0.000218	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—SRC—urinary bladder cancer	0.000111	0.000459	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—SRC—urinary bladder cancer	0.000111	0.000459	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—HPGDS—urinary bladder cancer	0.000111	0.000458	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ENO2—urinary bladder cancer	0.000111	0.000458	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EP300—urinary bladder cancer	0.00011	0.000455	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—EP300—urinary bladder cancer	0.00011	0.000455	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—HRAS—urinary bladder cancer	0.000109	0.000452	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—HRAS—urinary bladder cancer	0.000109	0.000452	CbGpPWpGaD
Lamotrigine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000109	0.000211	CcSEcCtD
Lamotrigine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000108	0.00021	CcSEcCtD
Lamotrigine—Vomiting—Methotrexate—urinary bladder cancer	0.000108	0.000209	CcSEcCtD
Lamotrigine—UGT1A3—Metabolism—GSTT1—urinary bladder cancer	0.000107	0.000444	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—NQO1—urinary bladder cancer	0.000107	0.000444	CbGpPWpGaD
Lamotrigine—Rash—Methotrexate—urinary bladder cancer	0.000107	0.000208	CcSEcCtD
Lamotrigine—SCN10A—Developmental Biology—SRC—urinary bladder cancer	0.000107	0.000442	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—SRC—urinary bladder cancer	0.000107	0.000442	CbGpPWpGaD
Lamotrigine—Dermatitis—Methotrexate—urinary bladder cancer	0.000107	0.000207	CcSEcCtD
Lamotrigine—Headache—Methotrexate—urinary bladder cancer	0.000106	0.000206	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	0.000106	0.000437	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—HRAS—urinary bladder cancer	0.000105	0.000436	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—HRAS—urinary bladder cancer	0.000105	0.000436	CbGpPWpGaD
Lamotrigine—Asthenia—Doxorubicin—urinary bladder cancer	0.000105	0.000204	CcSEcCtD
Lamotrigine—SCN5A—Axon guidance—SRC—urinary bladder cancer	0.000105	0.000436	CbGpPWpGaD
Lamotrigine—Dizziness—Epirubicin—urinary bladder cancer	0.000105	0.000204	CcSEcCtD
Lamotrigine—SCN8A—Developmental Biology—HRAS—urinary bladder cancer	0.000105	0.000434	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000104	0.000432	CbGpPWpGaD
Lamotrigine—Pruritus—Doxorubicin—urinary bladder cancer	0.000104	0.000202	CcSEcCtD
Lamotrigine—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	0.000103	0.000425	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EGFR—urinary bladder cancer	0.000101	0.000418	CbGpPWpGaD
Lamotrigine—Vomiting—Epirubicin—urinary bladder cancer	0.000101	0.000196	CcSEcCtD
Lamotrigine—Nausea—Methotrexate—urinary bladder cancer	0.000101	0.000196	CcSEcCtD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000101	0.000417	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—TNF—urinary bladder cancer	0.000101	0.000416	CbGpPWpGaD
Lamotrigine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000101	0.000195	CcSEcCtD
Lamotrigine—Rash—Epirubicin—urinary bladder cancer	0.0001	0.000194	CcSEcCtD
Lamotrigine—Dermatitis—Epirubicin—urinary bladder cancer	0.0001	0.000194	CcSEcCtD
Lamotrigine—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	9.99e-05	0.000413	CbGpPWpGaD
Lamotrigine—Headache—Epirubicin—urinary bladder cancer	9.95e-05	0.000193	CcSEcCtD
Lamotrigine—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	9.72e-05	0.000402	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EGFR—urinary bladder cancer	9.72e-05	0.000402	CbGpPWpGaD
Lamotrigine—Dizziness—Doxorubicin—urinary bladder cancer	9.71e-05	0.000188	CcSEcCtD
Lamotrigine—SCN3A—Developmental Biology—TNF—urinary bladder cancer	9.63e-05	0.000398	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—KRAS—urinary bladder cancer	9.55e-05	0.000395	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	9.5e-05	0.000393	CbGpPWpGaD
Lamotrigine—Nausea—Epirubicin—urinary bladder cancer	9.43e-05	0.000183	CcSEcCtD
Lamotrigine—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	9.37e-05	0.000388	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	9.37e-05	0.000388	CbGpPWpGaD
Lamotrigine—Vomiting—Doxorubicin—urinary bladder cancer	9.34e-05	0.000181	CcSEcCtD
Lamotrigine—Rash—Doxorubicin—urinary bladder cancer	9.26e-05	0.00018	CcSEcCtD
Lamotrigine—SCN2A—Developmental Biology—TNF—urinary bladder cancer	9.25e-05	0.000383	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—TNF—urinary bladder cancer	9.25e-05	0.000383	CbGpPWpGaD
Lamotrigine—Dermatitis—Doxorubicin—urinary bladder cancer	9.25e-05	0.00018	CcSEcCtD
Lamotrigine—SCN5A—Axon guidance—EGFR—urinary bladder cancer	9.23e-05	0.000382	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	9.23e-05	0.000382	CbGpPWpGaD
Lamotrigine—Headache—Doxorubicin—urinary bladder cancer	9.2e-05	0.000179	CcSEcCtD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	9.19e-05	0.00038	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	9.18e-05	0.00038	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—KRAS—urinary bladder cancer	9.18e-05	0.00038	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	9.15e-05	0.000378	CbGpPWpGaD
Lamotrigine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	8.98e-05	0.000372	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GSTP1—urinary bladder cancer	8.95e-05	0.00037	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—TNF—urinary bladder cancer	8.92e-05	0.000369	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—TNF—urinary bladder cancer	8.92e-05	0.000369	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—NQO1—urinary bladder cancer	8.92e-05	0.000369	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	8.85e-05	0.000366	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	8.85e-05	0.000366	CbGpPWpGaD
Lamotrigine—Nausea—Doxorubicin—urinary bladder cancer	8.73e-05	0.000169	CcSEcCtD
Lamotrigine—SCN5A—Axon guidance—KRAS—urinary bladder cancer	8.72e-05	0.000361	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	8.49e-05	0.000351	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	8.45e-05	0.000349	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—TYMS—urinary bladder cancer	8.32e-05	0.000344	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—NCOR1—urinary bladder cancer	8.22e-05	0.00034	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GSTM1—urinary bladder cancer	8.22e-05	0.00034	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	8.15e-05	0.000337	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—HRAS—urinary bladder cancer	8.12e-05	0.000336	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	8.02e-05	0.000332	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	8.01e-05	0.000331	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NAT1—urinary bladder cancer	8.01e-05	0.000331	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.92e-05	0.000328	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GPX1—urinary bladder cancer	7.87e-05	0.000326	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—HRAS—urinary bladder cancer	7.8e-05	0.000323	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	7.8e-05	0.000323	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ERCC2—urinary bladder cancer	7.73e-05	0.00032	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EP300—urinary bladder cancer	7.73e-05	0.00032	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	7.52e-05	0.000311	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	7.52e-05	0.000311	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—SRC—urinary bladder cancer	7.52e-05	0.000311	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GSTP1—urinary bladder cancer	7.44e-05	0.000308	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—HRAS—urinary bladder cancer	7.41e-05	0.000307	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	7.32e-05	0.000303	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—MTHFR—urinary bladder cancer	7.27e-05	0.000301	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—TYMS—urinary bladder cancer	6.91e-05	0.000286	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GSTM1—urinary bladder cancer	6.84e-05	0.000283	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—NCOR1—urinary bladder cancer	6.84e-05	0.000283	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.8e-05	0.000281	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	6.72e-05	0.000278	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	6.59e-05	0.000273	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	6.59e-05	0.000272	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	6.57e-05	0.000272	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GPX1—urinary bladder cancer	6.55e-05	0.000271	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ERCC2—urinary bladder cancer	6.43e-05	0.000266	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—TNF—urinary bladder cancer	6.27e-05	0.000259	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	6.23e-05	0.000258	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	6.22e-05	0.000257	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	6.07e-05	0.000251	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—MTHFR—urinary bladder cancer	6.04e-05	0.00025	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.93e-05	0.000245	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PPARG—urinary bladder cancer	5.89e-05	0.000244	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.74e-05	0.000237	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.73e-05	0.000237	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CREBBP—urinary bladder cancer	5.66e-05	0.000234	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	5.46e-05	0.000226	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.31e-05	0.00022	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	5.29e-05	0.000219	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PPARG—urinary bladder cancer	4.9e-05	0.000203	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.85e-05	0.000201	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.76e-05	0.000197	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CREBBP—urinary bladder cancer	4.71e-05	0.000195	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.66e-05	0.000193	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PTGS2—urinary bladder cancer	4.64e-05	0.000192	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.43e-05	0.000183	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.4e-05	0.000182	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NAT2—urinary bladder cancer	4.39e-05	0.000181	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PTEN—urinary bladder cancer	4.04e-05	0.000167	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.91e-05	0.000162	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—EP300—urinary bladder cancer	3.86e-05	0.000159	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	3.85e-05	0.000159	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.79e-05	0.000157	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.51e-05	0.000145	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.51e-05	0.000145	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.4e-05	0.000141	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PTEN—urinary bladder cancer	3.36e-05	0.000139	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—EP300—urinary bladder cancer	3.2e-05	0.000133	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.18e-05	0.000132	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.83e-05	0.000117	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.36e-05	9.75e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.19e-05	9.06e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.17e-05	8.96e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.17e-05	8.96e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.07e-05	8.58e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.04e-05	8.42e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.91e-05	7.92e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.55e-05	6.42e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.49e-05	6.17e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.22e-05	5.05e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.07e-05	4.41e-05	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.02e-05	4.2e-05	CbGpPWpGaD
